128 related articles for article (PubMed ID: 27878296)
21. Hepatitis B virus enhances cisplatin-induced hepatotoxicity via a mechanism involving suppression of glucose-regulated protein of 78 Kda.
Zhang X; Zhang R; Yang H; Xiang Q; Jiang Q; He Q; Zhang T; Chen C; Zhu H; Wang Q; Ning Q; Li Y; Lei P; Shen G
Chem Biol Interact; 2016 Jul; 254():45-53. PubMed ID: 27234046
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.
Wang Y; Cai J; Zeng X; Chen Y; Yan W; Ouyang Y; Xiao D; Zeng Z; Huang L; Liu A
BMC Cancer; 2015 Oct; 15():821. PubMed ID: 26514586
[TBL] [Abstract][Full Text] [Related]
23. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo.
Wong VK; Chiu P; Chung SS; Chow LM; Zhao YZ; Yang BB; Ko BC
Clin Cancer Res; 2005 Aug; 11(16):6002-11. PubMed ID: 16115945
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular Carcinoma.
Honda M; Shirasaki T; Terashima T; Kawaguchi K; Nakamura M; Oishi N; Wang X; Shimakami T; Okada H; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
J Infect Dis; 2016 Apr; 213(7):1096-106. PubMed ID: 26621908
[TBL] [Abstract][Full Text] [Related]
25. Butyrate inhibits HBV replication and HBV-induced hepatoma cell proliferation via modulating SIRT-1/Ac-p53 regulatory axis.
Pant K; Mishra AK; Pradhan SM; Nayak B; Das P; Shalimar D; Saraya A; Venugopal SK
Mol Carcinog; 2019 Apr; 58(4):524-532. PubMed ID: 30501014
[TBL] [Abstract][Full Text] [Related]
26. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
[TBL] [Abstract][Full Text] [Related]
27. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
[TBL] [Abstract][Full Text] [Related]
28. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
29. Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis.
Zou C; Chen J; Chen K; Wang S; Cao Y; Zhang J; Sheng Y; Huang A; Tang H
Exp Cell Res; 2015 Feb; 331(2):352-61. PubMed ID: 25449696
[TBL] [Abstract][Full Text] [Related]
30. Modulation of hepatitis B surface antigen secretion by annexin II expressed in hepatitis B virus‑producing hepatoma cells.
Liu Y; Gao P
Mol Med Rep; 2014 Dec; 10(6):3113-7. PubMed ID: 25270731
[TBL] [Abstract][Full Text] [Related]
31. Glucose-regulated protein 78 demonstrates antiviral effects but is more suitable for hepatocellular carcinoma prevention in hepatitis B.
Zheng NQ; Zheng ZH; Xu HX; Huang MX; Peng XM
Virol J; 2017 Apr; 14(1):77. PubMed ID: 28407787
[TBL] [Abstract][Full Text] [Related]
32. Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib.
Mao K; Zhang J; He C; Xu K; Liu J; Sun J; Wu G; Tan C; Zeng Y; Wang J; Xiao Z
Cancer Lett; 2014 Oct; 352(2):245-52. PubMed ID: 25034398
[TBL] [Abstract][Full Text] [Related]
33. Role of pseudolaric acid B in A549 lung cancer cell proliferation and apoptosis.
Guan T; Yang Y
Mol Med Rep; 2014 Jan; 9(1):144-8. PubMed ID: 24248012
[TBL] [Abstract][Full Text] [Related]
34. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
35. Dual effects of interleukin-18: inhibiting hepatitis B virus replication in HepG2.2.15 cells and promoting hepatoma cells metastasis.
Zhang Y; Li Y; Ma Y; Liu S; She Y; Zhao P; Jing M; Han T; Yan C; Wu Z; Gao J; Ye L
Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G565-73. PubMed ID: 21719740
[TBL] [Abstract][Full Text] [Related]
36. Defective DNA damage response and repair in liver cells expressing hepatitis B virus surface antigen.
Chung YL
FASEB J; 2013 Jun; 27(6):2316-27. PubMed ID: 23444429
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
38. [Hepatitis B virus X promotes HepG2 cell cycle progression and growth via downregulation expression of p16 protein].
Mai L; Yang L; Kuang JY; Zhu JY; Kang YH; Zhang FC; Xie QF; Gao ZL
Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):614-8. PubMed ID: 24119743
[TBL] [Abstract][Full Text] [Related]
39. [Study on the apoptosis inducing effect of pseudolaric acid B on cervical carcinoma cell line HeLa cells].
Hu Y; Wu XK; Hou LH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jul; 30(7):720-2. PubMed ID: 20929130
[TBL] [Abstract][Full Text] [Related]
40. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]